Naslov
LEUKOPENIJA KAO JEDINI SIMPTOM KOVID-19 KOD PACIJENATA OBOLELIH OD SHIZOFRENIJE NA TERAPIJI KLOZAPINOM
(Leukopenia as the only symptom of COVID-19 in patients with schizophrenia on Clozapine therapy)

Autori
Greš, A ; Staver, Dijana, Šagud, Marina

Izvornik
Engrami (0351-2665) 44 (1) (2022); 80-88

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, prikaz, stručni

Ključne riječi
COVID-19, SARS CoV 2, klozapin shizofrenija, leukopenija, neutropenija, asimptomatski
(COVID-19, SARS CoV 2, Clozapine, Schizophrenia, Leukopenia, Neutropenia, Asymptomatic)

Sažetak
Patients suffering from Covid-19 often have leukopenia, most often lymphopenia, as an accompanying laboratory manifestation of the clinical syndrome, but there are indications that at the beginning of the disease they also have mild neutropenia. Clozapine can have hematological side effects in terms of leukopenia - most often neutropenia. The paper presents a patient with schizophrenia who is on long-term Clozapine therapy. At the time when leukopenia was detected in the blood count, he was mentally stable and physically asymptomatic. He had a reduced number of leukocytes as the only symptom of infection with the new coronavirus SARS CoV 2, which we confirmed by PCR. In this paper, we present the clinical picture of COVID-19 in connection with the possible overlapping etiology of leukopenia, which can also appear as a separate symptom of infection with the SARS CoV 2 coronavirus and be a hematological side effect of Clozapine treatment.

Izvorni jezik
Ostalo

POVEZANOST RADA